The health care sector closed the day up 0.5%. Rosetta Genomics ( ROSG), Rosetta Genomics ( ROSGD), Tibet Pharmaceuticals Inc ( TBET), and Medtox Scientific Inc ( MTOX) were all decliners today within the health care sector with Hospira Inc ( HSP) being today's featured health care loser. Hospira Inc fell 74 cents (-1.9%) to $38.02 on light volume. Throughout the day, 940,492 shares of Hospira Inc exchanged hands as compared to its average daily volume of 1.5 million shares.

Hospira, Inc., a specialty pharmaceutical and medication delivery company, develops, manufactures, and markets pharmaceuticals and medication delivery systems in the United States and internationally. Hospira Inc has a market cap of $6.3 billion and is part of the drugs industry. The company has a P/E ratio of 17.7, above the average drugs industry P/E ratio of 15.3 and equal to the S&P 500 P/E ratio of 17.7. Shares are down 30.4% year to date as of the close of trading on Wednesday.

TheStreet Ratings rates Hospira as a hold. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and disappointing return on equity.

On the positive front, K-V Pharmaceutical Company ( KV.A), Cyclacel Pharmaceuticals Inc ( CYCC), K-V Pharmaceutical Company ( KV.B), and Escalon Medical Corporation ( ESMC) were all gainers within the health care sector with Eli Lilly and Company ( LLY) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).